CUSIP No. 0004417961 Page 1 of 10 Pages
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
SCHEDULE 13G
Information Statement pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. )
Housecall Medical Resources, Inc.
_________________________________________________________________
(Name of Issuer)
Common Stock
_________________________________________________________________
(Title of Class of Securities)
0004417961
__________________________________________________________________
(CUSIP Number)
________________________
<PAGE>
CUSIP No. 0004417961 Page 2 of 10 Pages
_________________________________________________________________
1) Name of Reporting Person Welsh, Carson,
S.S. or I.R.S. Identification Anderson & Stowe VI,
No. of Above Person L.P.
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of 5) Sole Voting 4,651,614 shares of
Shares Beneficially Power Common Stock
Owned by Each
Reporting Person
With: ________________________________________
6) Shared Voting
Power -0-
________________________________________
7) Sole Disposi- 4,651,614 shares of
tive Power Common Stock
________________________________________
8) Shared Dis-
positive Power -0-
________________________________________
9) Aggregate Amount Beneficially 4,651,614 shares of
Owned by Each Reporting Person Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 45.5%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
_________________________________________________________________
<PAGE>
CUSIP No. 0004417961 Page 3 of 10 Pages
_________________________________________________________________
1) Name of Reporting Person WCAS Healthcare
S.S. or I.R.S. Identification Partners, L.P.
No. of Above Person
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of 5) Sole Voting 155,465 shares of
Shares Beneficially Power Common Stock
Owned by Each
Reporting Person
With: ________________________________________
6) Shared Voting
Power -0-
________________________________________
7) Sole Disposi- 155,465 shares of
tive Power Common Stock
_______________________________________
8) Shared Dis-
positive Power -0-
________________________________________
9) Aggregate Amount Beneficially 155,465 shares of
Owned by Each Reporting Person Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 1.5%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 0004417961 Page 4 of 10 Pages
_________________________________________________________________
1) Name of Reporting Person WCAS Capital
S.S. or I.R.S. Identification Partners II, L.P.
No. of Above Person
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of 5) Sole Voting 454,050 shares of
Shares Beneficially Power Common Stock
Owned by Each
Reporting Person
With: ________________________________________
6) Shared Voting
Power -0-
________________________________________
7) Sole Disposi- 454,050 shares of
tive Power Common Stock
_______________________________________
8) Shared Dis-
positive Power -0-
________________________________________
9) Aggregate Amount Beneficially 454,050 shares of
Owned by Each Reporting Person Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 4.4%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
CUSIP No. 0004417961 Page 5 of 10 Pages
Schedule 13G
Item 1(a) - Name of Issuer: Housecall Medicall Resources, Inc.
Item 1(b) - Address of Issuer's Principal Executive Offices:
1000 Abernathy Road, Bldg. 400
Suite 1825
Atlanta, GA 30328
Item 2(a) - Name of Person Filing:
This statement is being filed by Welsh, Carson, Anderson &
Stowe VI, L.P., a Delaware limited partnership ("WCAS VI"),
WCAS Healthcare Partners, L.P., a Delaware limited
partnership ("Healthcare Partners"), and WCAS Capital
Partners II, L.P., a Delaware limited partnership ("Capital
Partners II") (collectively, the "Reporting Persons").
Item 2(b) - Address of Principal Business Office:
320 Park Avenue, Suite 2500
New York, New York 10022
Item 2(c) - Place of Organization:
WCAS VI: Delaware
Healthcare Partners: Delaware
Capital Partners II: Delaware
Item 2(d) - Title of Class of Securities:
Common Stock
Item 2(e) - CUSIP Number: 0004417961
<PAGE>
CUSIP No. 0004417961 Page 6 of 10 Pages
Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b):
Not applicable.
Item 4 - Ownership.
(a) Amount Beneficially Owned:
WCAS VI: 4,651,614 shares of Common Stock
Healthcare Partners: 155,465 shares of Common
Stock
Capital Partners II: 454,050 shares of Common
Stock
(b) Percent of Class:
WCAS VI: 45.5%
Healthcare Partners: 4.4%
Capital Partners II: 1.5%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: WCAS
VI: 4,651,614 shares
Healthcare Partners: 155,465 shares
Capital Partners II: 454,050 shares
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition
of:
WCAS VI: 4,651,614 shares
Healthcare Partners: 155,465 shares
Capital Partners II: 454,050 shares
(iv) shared power to dispose or to direct the
disposition of: -0-
Item 5 - Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6 - Ownership of More than Five Percent on Behalf of Another
Person:
Not applicable.
<PAGE>
CUSIP No. 0004417961 Page 7 of 10 Pages
Item 7 - Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent
Company:
Not applicable.
Item 8 - Identification and Classification of Members of the Group:
See Exhibit 2.
Item 9 - Notice of Dissolution of Group:
Not applicable.
Item 10 - Certification:
Not applicable.
<PAGE>
CUSIP No. 0004417961 Page 8 of 10 Pages
Signature:
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
WELSH, CARSON, ANDERSON & STOWE VI, L.P.
By: WCAS VI Partners, L.P., General Partner
By /s/ Laura VanBuren
General Partner
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Russell L. Carson
General Partner
WCAS CAPITAL PARTNERS II, L.P.
By: WCAS CP II Partners, General Partner
By /s/ Laura VanBuren
General Partner
Date: January 21, 1997
CUSIP No. 0004417961 Page 9 of 10 Pages
EXHIBIT 1
AGREEMENT
OF
WELSH, CARSON, ANDERSON & STOWE VI, L.P.,
WCAS HEALTHCARE PARTNERS, L.P.
AND
WCAS CAPITAL PARTNERS II, L.P.
PURSUANT TO RULE 13d-1(f)
_________________________
The undersigned hereby agree that the Information Statement on
Schedule 13G to which this Agreement is annexed as Exhibit 1 is filed on
behalf of each of them in accordance with the provisions of Rule 13d-1(f)
under the Securities Exchange Act of 1934, as amended.
WELSH, CARSON, ANDERSON & STOWE VI, L.P.
By: WCAS VI Partners, L.P., General Partner
By /s/ Laura VanBuren
General Partner
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Russell L. Carson
General Partner
WCAS CAPITAL PARTNERS II, L.P.
By: WCAS CP II Partners, General Partner
By /s/ Laura VanBuren
General Partner
Date: January 21, 1997
<PAGE>
CUSIP No. 0004417961 Page 10 of 10 Pages
EXHIBIT 2
Identification and Classification
of Members of the Group
_________________________________
Welsh, Carson, Anderson & Stowe VI, L.P., WCAS Healthcare
Partners, L.P. and WCAS Capital Partners II, L.P. are filing this
statement on Schedule 13G as a group.
Welsh, Carson, Anderson & Stowe VI, L.P. is a Delaware
limited partnership. Its sole general partner is WCAS VI Partners,
L.P., a Delaware limited partnership.
WCAS Healthcare Partners, L.P. is a Delaware limited
partnership. Its sole general partner is WCAS HP Partners, a Delaware
general partnership.
WCAS Capital Partners II, L.P. is a Delaware limited
partnership. Its sole general partner is WCAS CP II Partners, a New
Jersey general partnership.
